Dow Up 1.03% Nasdaq Up 1.36%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.08 Down 0.05(1.11%) 1:21PM EDT - Nasdaq Real Time Price
Prev Close:4.13
Open:4.21
Bid:4.08 x 2400
Ask:4.09 x 2100
1y Target Est:11.00
Beta:3.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.00 - 4.25
52wk Range:3.11 - 7.82
Volume:1,049,078
Avg Vol (3m):4,153,940
Market Cap:500.45M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OREX

Comparison

Symbol% ChgMkt Cap
OREXDown 1.11%500.45M
ABTUp 0.05%65.43B
GSKUp 0.78%109.36B
RHHBYDown 1.00%250.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):147.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.30
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback